Neurocrine Biosciences, Inc. (0K6R.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 14.12B |
| Enterprise Value | 14.29B |
| P/E Ratio | 20.31 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 4.27 |
| Price/Book Ratio | 3.92 |
| Enterprise/Revenue | 4.29 |
| Enterprise/EBITDA | 15.76 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.21 |
| Operating Margin | 0.23 |
AD
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 2.86B |
| Revenue/Share | 33.4 |
| Gross Profit | 2.81B |
| EBITDA | 666.6M |
| Net Income | 478.6M |
| Diluted EPS | 4.67 |
Balance Sheet
| Total Cash | 389.8M |
| Total Cash/Share | 3.86 |
| Total Debt | 401.8M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 1.87 |
| Book Value Per Share | 36.57 |
Price History
| 52-Week Change | 4.58 |
| 52-Week High | 190 |
| 52-Week Low | 89.66 |
| Moving Average 50 Days | 135.58 |
| Moving Average 200 Days | 114.15 |
Statistics
| Average Volume | 1,189 |
| Shares Outstanding | 100.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
